|
| |
| | | 69313 | | 25.10.2024 | | Mepha Pharma AG | | | | | | | 24.10.2029 | | | | | | | | | | 01.06. | | |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Bupropion-Mepha XR 150 mg | Retardtabletten | Retard-Tabletten (Bupropion Hydrochlorid 150 mg) | N06AX12 | | | 02 | Bupropion-Mepha XR 300 mg | Retardtabletten | Retard-Tabletten (Bupropion Hydrochlorid 300 mg) | N06AX12 | |
|
|
|
